Regenx Granted Management Cease Trade Order by the ASC

‎The MCTO restricts the Chief Executive Officer and Chief Financial Officer from all ‎trading in securities of the Corporation until such time as the required documents have ‎been filed by the Corporation and the MCTO ‎is no longer in effect. The MCTO does not affect the ability of ‎other shareholders of ‎the Corporation to trade their securities. Regenx and the auditor continue to work diligently toward completing the filings as soon as possible with the goal of filing by May 29, 2024. ‎ Read More